** BlinkLab BB1.AX jumps as much as 9.2% to A$0.9; marks biggest intraday pct gain in a month
** Stock touches highest since December 16
** Digital healthcare firm says scientific paper validating its smartphone-based tech published in popular journal Autism Research
** Adds paper validates co's tech that uses smartphones to measure neurophysiological responses such as facial reflexes among others at home
** BB1 surged more than 150% in 2025
(Reporting by Aamir Sheik Khalid in Bengaluru)
((Aamir.SheikKhalid@thomsonreuters.com))